WIL Research Laboratories

WIL Research Laboratories, LLC (acquired in 2016 and renamed Charles River Laboratories Ashland, LLC) was a contract research organization (CRO), privately held for 40 years, that provided product safety toxicological research, metabolism, bioanalytical, pharmacological, and formulation services to the pharmaceutical, biotechnology, chemical, agrochemical, and food products industries, as well as manufacturing support for clinical trials. WIL Research was well-known internationally in many disciplines, and considered by many industry experts to be the premier laboratory in the world for developmental and reproductive toxicology (DART).

WIL Research Laboratories was founded in 1976 in Cincinnati, Ohio by G. Bruce Briggs, Ralph S. Hodgdon, and Robert W. Brigham, with Briggs serving as the company's first president.^{[citation needed]} The company was initially a limited mammalian toxicological testing laboratory that conducted short-term studies for several clients in the Cincinnati area. In 1978, Great Lakes Chemical Corporation acquired WIL Research Laboratories. By 1980, WIL Research outgrew its facilities in Cincinnati, subsequently acquired the 75-acre Hess & Clark research facility on the outskirts of Ashland, Ohio, and by 1982 had moved its operations to the new location. The move to Ashland enabled WIL to conduct a larger number of studies as it began to expand its client base.

Dr. Joseph F. Holson was named President and Director of WIL Research Laboratories in 1988. Under his leadership over the next 20 years, WIL Research grew from 31 employees into a dynamic contract research organization employing more than 600 individuals at the Ashland site. This success was attributed to the company's entrepreneurial scientific management, study director-centric business model, internationally recognized scientific prowess (particularly in DART), internally developed innovations (including the industry's first protocol-driven toxicology data management software system), and strong involvement in the Ashland community.

During Holson's tenure, WIL Research continuously expanded its scientific capabilities, facilities, and staffing levels. During this period, the company grew from a limited mammalian toxicology research laboratory into a robust interdisciplinary CRO offering developmental and reproductive toxicology, neurotoxicology, inhalation toxicology, developmental neurotoxicology, large animal toxicology, juvenile toxicology, safety pharmacology, metabolism, analytical and bioanalytical chemistry, and formulation services to a globally diverse client base. Underpinning the continuous expansion of service capabilities was a steady expansion of the company's facilities from approximately 30,000 square feet to more than 300,000 square feet of dedicated laboratory, vivarium, and support services space.

At the heart of Dr. Holson's vision, though, was a drive to continually deepen the company's talent pool, as the number of employees in Ashland grew from 31 to more than 600. Joseph Holson was well-known as an energetic, outgoing leader with a vision for the company that revolved around the success of his staff and ongoing recruitment efforts. Critical to the success of WIL Research was a continuous investment in staff training, as new biologists typically underwent a 9-12 month training period and all employees regularly completed continuing education not only in their specific areas of expertise but also in the subjects of animal care and welfare, Good Laboratory Practices, and research integrity. Many of the internal training programs developed at WIL Research were highly regarded and requested by clients and industry partners.

A key driver of WIL's steady growth was its study director-centric business model, which viewed each study director as an individual business unit with scientific, project management, and marketing responsibilities. This approach was in contrast to the typical division within CROs between science and marketing. WIL Research emphasized direct scientist-to-scientist interaction as much as possible across the entire scope of each project, which gained the company numerous accolades from its clients. Examples of the types of projects undertaken by WIL Research included studies of drugs for the treatment of herpes, Alzheimers' disease, glaucoma, cancer, and AIDS, numerous pesticides, and replacement chemicals for ozone-depleting chlorofluorocarbons in fire extinguishers.

Although highly respected in many disciplines, WIL Research was considered by many to be the leading laboratory in the world for developmental and reproductive toxicology (DART). This leadership was driven by Dr. Joseph Holson, an internationally recognized authority in the field. The DART division at WIL Research, led initially by Dr. Holson and subsequently by Mr. Mark D. Nemec and Dr. Donald G. Stump, became known not only for high-quality regulatory guideline studies, but also for innovative, specialized DART research.

In 1978, as a result of expanding toxicology testing services, the WIL Toxicology Data Management System (WTDMS™) was developed. This protocol-driven software system was the first in the CRO industry and became the prototype for other major toxicology testing laboratories. WTDMS™ was licensed to several other toxicology testing laboratories, and was used continuously by WIL Research Laboratories for nearly forty years prior to its gradual replacement by the Provantis system.